ReviewFrontiers in pharmacology2016

Cannabidiol as a Potential New Type of an Antipsychotic. A Critical Review of the Evidence.

Cathrin Rohleder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.